← Back to Discover
ADAR1 Capital Management, LLC
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $2,185,183,006
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $240,494,722
- PROTAGONIST THERAPEUTICS INC · COM · 74366E102 · shares: $117,782,587
- ROIVANT SCIENCES LTD · SHS · G76279101 · shares: $111,726,513
- STATE STR SPDR S&P 500 ETF T · TR UNIT · 78462F103 · shares: $96,398,299
- IMMUNOVANT INC · COM · 45258J102 · shares: $89,802,487
- ZAI LAB LTD · ADR · 98887Q104 · shares: $64,011,646
- AGIOS PHARMACEUTICALS INC · COM · 00847X104 · shares: $47,799,647
- CRINETICS PHARMACEUTICALS IN · COM · 22663K107 · shares: $45,730,234
- EA SERIES TRUST · ALPHA ARCH 1-3 · 02072L565 · shares: $39,473,966
- CYTOKINETICS INC · COM NEW · 23282W605 · shares: $39,009,097
Reported holdings
277 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| SEAPORT THERAPEUTICS INC | COMMON STOCK | 81221K108 | — | 26,000 shares | $564,720 |
| CORBUS PHARMACEUTICALS HLDGS | COM NEW | 21833P301 | CALL | 60,000 shares | $562,800 |
| ASSEMBLY BIOSCIENCES INC | COM NEW | 045396207 | — | 20,447 shares | $561,884 |
| CYBIN INC | COM NEW | 23256X407 | — | 81,278 shares | $537,248 |
| BENITEC BIOPHARMA INC | COM NEW | 08205P209 | — | 40,000 shares | $535,200 |
| POLYPID LTD | COM | M8001Q126 | — | 103,950 shares | $528,066 |
| PULMONX CORP | COM | 745848101 | — | 404,497 shares | $525,846 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | — | 27,000 shares | $525,690 |
| GLOBA TERRA ACQUISITION COR | UNIT 99/99/9999 | G3933N108 | — | 50,000 shares | $519,500 |
| TRAWS PHARMA INC | COM NEW | 68232V884 | — | 597,729 shares | $504,065 |
| WISDOMTREE TR | FLOATNG RAT TREA | 97717Y527 | — | 10,000 shares | $503,500 |
| TECTONIC THERAPEUTIC INC | COM | 878972108 | — | 14,501 shares | $498,472 |
| MADRIGAL PHARMACEUTICALS INC | COM | 558868105 | — | 895 shares | $480,570 |
| ARVINAS INC | COM | 04335A105 | — | 57,591 shares | $478,581 |
| ORTHOPEDIATRICS CORP | COM | 68752L100 | — | 25,000 shares | $478,250 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 12,200 shares | $472,140 |
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | — | 42,900 shares | $465,465 |
| MIRUM PHARMACEUTICALS INC | COM | 604749101 | — | 3,900 shares | $456,573 |
| KIORA PHARMACEUTICALS INC | COM | 49721T507 | — | 167,941 shares | $441,685 |
| KURA ONCOLOGY INC | COM | 50127T109 | — | 40,000 shares | $438,800 |
| CONTEXT THERAPEUTICS INC | COM | 21077P108 | — | 750,969 shares | $415,962 |
| ISHARES TR | 0-5 YR TIPS ETF | 46429B747 | — | 4,000 shares | $408,640 |
| KALARIS THERAPEUTICS INC | COM | 482929106 | — | 100,000 shares | $407,000 |
| BICARA THERAPEUTICS INC | COM | 055477103 | — | 13,705 shares | $406,901 |
| MERCK & CO INC | COM | 58933Y105 | — | 3,140 shares | $403,490 |
| NEUMORA THERAPEUTICS INC. | COM | 640979100 | — | 210,000 shares | $357,000 |
| IRHYTHM HOLDINGS INC | COM | 450056106 | — | 3,000 shares | $356,850 |
| ACHIEVE LIFE SCIENCE INC | COM | 004468500 | — | 53,800 shares | $351,314 |
| ALIBABA GROUP HLDG LTD | SPONSORED ADS | 01609W102 | — | 3,578 shares | $343,416 |
| WW INTL INC | COM NEW | 98262P200 | — | 21,300 shares | $340,374 |
| CNS PHARMACEUTICALS INC | COM | 18978H508 | — | 70,000 shares | $334,600 |
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | — | 18,275 shares | $328,950 |
| BOSTON SCIENTIFIC CORP | COM | 101137107 | — | 7,500 shares | $320,100 |
| ALTIMMUNE INC | COM NEW | 02155H200 | — | 102,823 shares | $312,582 |
| VERASTEM INC | COM NEW | 92337C203 | — | 75,800 shares | $289,556 |
| AN2 THERAPEUTICS INC | COM | 037326105 | — | 58,808 shares | $284,631 |
| JOURNEY MED CORP | COM | 48115J109 | — | 39,517 shares | $279,780 |
| PROCAP ACQUISITION CORP | UNIT 05/16/2030 | G7257A113 | — | 26,940 shares | $279,368 |
| PMV PHARMACEUTICALS INC | COM | 69353Y103 | — | 201,008 shares | $269,351 |
| COMPASS THERAPEUTICS INC | COM | 20454B104 | — | 122,132 shares | $267,469 |
| JD.COM INC | SPON ADS CL A | 47215P106 | — | 10,000 shares | $254,800 |
| REZOLUTE INC | COM NEW | 76200L309 | — | 48,679 shares | $253,131 |
| ANAPTYSBIO INC | COM | 032724106 | — | 3,698 shares | $249,615 |
| NEUROGENE INC | COM | 64135M105 | — | 7,800 shares | $245,310 |
| ISHARES TR | U.S. MED DVC ETF | 464288810 | — | 4,900 shares | $242,109 |
| RXSIGHT INC | COM | 78349D107 | — | 50,000 shares | $241,000 |
| COYA THERAPEUTICS INC | COMMON STOCK | 22407B108 | — | 40,900 shares | $239,265 |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | — | 50,638 shares | $214,705 |
| CANTOR EQUITY PARTNERS VI IN | CL A ORD SHS | G1828R101 | — | 20,000 shares | $207,400 |
| SCYNEXIS INC | COM | 811292309 | — | 49,387 shares | $201,005 |
| PERSONALIS INC | COM | 71535D106 | — | 15,000 shares | $201,000 |
| Q/C TECHNOLOGIES INC | COM | 62856X300 | — | 50,000 shares | $195,000 |
| CABALETTA BIO INC | COM | 12674W109 | — | 50,000 shares | $155,500 |
| RECURSION PHARMACEUTICALS IN | CL A | 75629V104 | — | 41,000 shares | $150,470 |
| ORGANON & CO | COMMON STOCK | 68622V106 | — | 10,000 shares | $135,400 |
| MILESTONE PHARMACEUTICALS IN | COM | 59935V107 | — | 100,000 shares | $134,000 |
| NEUPHORIA THERAPEUTICS INC | COM | 64136E102 | — | 30,000 shares | $131,100 |
| NEURONETICS INC | COM | 64131A105 | — | 100,000 shares | $130,000 |
| CHEMOMAB THERAPEUTICS LTD | SPONSORED ADS | 16385C203 | — | 80,000 shares | $129,600 |
| SOLIDION TECHNOLOGY INC | COM NEW | 834212201 | CALL | 13,500 shares | $125,415 |
| VOYAGER THERAPEUTICS INC | COM | 92915B106 | — | 35,000 shares | $122,500 |
| ENTRADA THERAPEUTICS INC | COM | 29384C108 | — | 15,500 shares | $114,080 |
| VERU INC | COM NEW | 92536C202 | — | 35,000 shares | $109,550 |
| CANTOR EQUITY PARTNERS VII I | CL A ORD SHS | G1828W100 | — | 10,000 shares | $100,900 |
| CLENE INC | COM NEW | 185634201 | — | 15,000 shares | $92,325 |
| VISTAGEN THERAPEUTICS INC | COM | 92840H400 | — | 351,141 shares | $79,358 |
| LONGEVERON INC | CL A NEW | 54303L203 | — | 108,406 shares | $76,209 |
| BIOMEA FUSION INC | COM | 09077A106 | — | 43,420 shares | $63,827 |
| LITE STRATEGY INC | COM | 55279B301 | — | 67,292 shares | $62,070 |
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | — | 140,000 shares | $58,940 |
| ARDELYX INC | COM | 039697107 | — | 11,000 shares | $56,100 |
| GOSSAMER BIO INC | COM | 38341P102 | — | 212,531 shares | $34,983 |
| ATYR PHARMA INC | COM NEW | 002120202 | — | 50,685 shares | $30,249 |
| A SPAC III ACQUISITION CORP | RIGHT 01/02/2026 | G0544A145 | — | 215,000 shares | $19,114 |
| PROQR THRAPEUTICS N V | SHS EURO | N71542109 | — | 10,000 shares | $18,600 |
| BEST SPAC I ACQUISITION CORP | RIGHT 05/27/2030 | G1069P129 | — | 100,000 shares | $16,560 |
| COHERUS ONCOLOGY INC | COM | 19249H103 | — | 10,366 shares | $14,512 |